Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 May;53(5):1441–1446. doi: 10.1172/JCI107692

Adrenergic Modulation of Pancreatic Glucagon Secretion in Man

John E Gerich 1, Maurice Langlois 1, Claudio Noacco 1, Victor Schneider 1, Peter H Forsham 1
PMCID: PMC302632  PMID: 4825234

Abstract

In order to characterize the influence of the adrenergic system on pancreatic glucagon secretion in man, changes in basal glucagon secretion during infusions of pure alpha and beta adrenergic agonists and their specific antagonists were studied. During infusion of isoproterenol (3 μg/min), a beta adrenergic agonist, plasma glucagon rose from a mean (±SE) basal level of 104±10 to 171±15 pg/ml, P < 0.0002. Concomitant infusion of propranolol (80 μg/min), a beta adrenergic antagonist, prevented the effects of isoproterenol, although propranolol itself had no effect on basal glucagon secretion. During infusion of methoxamine (0.5 mg/min), an alpha adrenergic agonist, plasma glucagon declined from a mean basal level of 122±15 to 75±17 pg/ml, P < 0.001. Infusion of phentolamine (0.5 mg/min), an alpha adrenergic antagonist, caused a rise in plasma glucagon from a mean basal level of 118±16 to 175±21 pg/ml, P < 0.0001. Concomitant infusion of methoxamine with phentolamine caused a reversal of the effects of phentolamine.

The present studies thus confirm that catecholamines affect glucagon secretion in man and demonstrate that the pancreatic alpha cell possesses both alpha and beta adrenergic receptors. Beta adrenergic stimulation augments basal glucagon secretion, while alpha adrenergic stimulation diminishes basal glucagon secretion. Furthermore, since infusion of phentolamine, an alpha adrenergic antagonist, resulted in an elevation of basal plasma glucagon levels, there appears to be an inhibitory alpha adrenergic tone governing basal glucagon secretion. The above findings suggest that catecholamines may influence glucose homeostasis in man through their effects on both pancreatic alpha and beta cell function.

Full text

PDF
1441

Images in this article

1442Image
on p.1442
1443Image
on p.1443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom S. R., Daniel P. M., Johnston D. I., Ogawa O., Pratt O. E. Release of glucagon, induced by stress. Q J Exp Physiol Cogn Med Sci. 1973 Jan;58(1):99–108. doi: 10.1113/expphysiol.1973.sp002195. [DOI] [PubMed] [Google Scholar]
  2. Böttger I., Schlein E. M., Faloona G. R., Knochel J. P., Unger R. H. The effect of exercise on glucagon secretion. J Clin Endocrinol Metab. 1972 Jul;35(1):117–125. doi: 10.1210/jcem-35-1-117. [DOI] [PubMed] [Google Scholar]
  3. Eaton R. P., Conway M., Buckman M. Role of alpha-adrenergic blockade on alanine-induced hyperglucagonemia. Metabolism. 1972 May;21(5):371–373. doi: 10.1016/0026-0495(72)90049-2. [DOI] [PubMed] [Google Scholar]
  4. Ensinck J. W., Shepard C., Dudl R. J., Williams R. H. Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma. J Clin Endocrinol Metab. 1972 Sep;35(3):463–467. doi: 10.1210/jcem-35-3-463. [DOI] [PubMed] [Google Scholar]
  5. Felig P., Wahren J., Hendler R., Ahlborg G. Plasma glucagon levels in exercising man. N Engl J Med. 1972 Jul 27;287(4):184–185. doi: 10.1056/NEJM197207272870412. [DOI] [PubMed] [Google Scholar]
  6. Frohman L. A., Bernardis L. L. Effect of hypothalamic stimulation on plasma glucose, insulin, and glucagon levels. Am J Physiol. 1971 Dec;221(6):1596–1603. doi: 10.1152/ajplegacy.1971.221.6.1596. [DOI] [PubMed] [Google Scholar]
  7. GRODSKY G. M., FORSHAM P. H. An immunochemical assay of total extractable insulin in man. J Clin Invest. 1960 Jul;39:1070–1079. doi: 10.1172/JCI104122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gerich J. E., Karam J. H., Forsham P. H. Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab. 1973 Sep;37(3):479–481. doi: 10.1210/jcem-37-3-479. [DOI] [PubMed] [Google Scholar]
  9. Gerich J. E., Langlois M., Noacco C., Karam J. H., Forsham P. H. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973 Oct 12;182(4108):171–173. doi: 10.1126/science.182.4108.171. [DOI] [PubMed] [Google Scholar]
  10. Gerich J. E., Schneider V., Dippe S. E., Langlois M., Noacco C., Karam J. H., Forsham P. H. Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Metab. 1974 Jan;38(1):77–82. doi: 10.1210/jcem-38-1-77. [DOI] [PubMed] [Google Scholar]
  11. Grey N., McGuigan J. E., Kipnis D. M. Neutralization of endogenous glucagon by high titer glucagon antiserum. Endocrinology. 1970 Jun;86(6):1383–1388. doi: 10.1210/endo-86-6-1383. [DOI] [PubMed] [Google Scholar]
  12. Iversen J. Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. J Clin Invest. 1973 Sep;52(9):2102–2116. doi: 10.1172/JCI107395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jenkinson D. H. Classification and properties of peripheral adrenergic receptors. Br Med Bull. 1973 May;29(2):142–147. doi: 10.1093/oxfordjournals.bmb.a070984. [DOI] [PubMed] [Google Scholar]
  14. Johnston D. I., Bloom S. R. Plasma glucagon levels in the term human infant and effect of hypoxia. Arch Dis Child. 1973 Jun;48(6):451–454. doi: 10.1136/adc.48.6.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Leclercq-Meyer V., Brisson G. R., Malaisse W. J. Effect of adrenaline and glucose on release of glucagon and insulin in vitro. Nat New Biol. 1971 Jun 23;231(25):248–249. doi: 10.1038/newbio231248a0. [DOI] [PubMed] [Google Scholar]
  16. Lefebvre P. The physiological effect of glucagon on fat-mobilisation. Diabetologia. 1966 Sep;2(2):130–132. doi: 10.1007/BF00423023. [DOI] [PubMed] [Google Scholar]
  17. Marliss E. B., Aoki T. T., Unger R. H., Soeldner J. S., Cahill G. F., Jr Glucagon levels and metabolic effects in fasting man. J Clin Invest. 1970 Dec;49(12):2256–2270. doi: 10.1172/JCI106445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Marliss E. B., Girardier L., Seydoux J., Wollheim C. B., Kanazawa Y., Orci L., Renold A. E., Porte D., Jr Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest. 1973 May;52(5):1246–1259. doi: 10.1172/JCI107292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Müller W. A., Faloona G. R., Unger R. H. Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med. 1973 Jan;54(1):52–57. doi: 10.1016/0002-9343(73)90083-1. [DOI] [PubMed] [Google Scholar]
  20. Porte D., Jr A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest. 1967 Jan;46(1):86–94. doi: 10.1172/JCI105514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Robertson R. P., Porte D., Jr Adrenergic modulation of basal insulin secretion in man. Diabetes. 1973 Jan;22(1):1–8. doi: 10.2337/diab.22.1.1. [DOI] [PubMed] [Google Scholar]
  22. Rocha D. M., Santeusanio F., Faloona G. R., Unger R. H. Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med. 1973 Apr 5;288(14):700–703. doi: 10.1056/NEJM197304052881402. [DOI] [PubMed] [Google Scholar]
  23. SAMOLS E., MARRI G., MARKS V. PROMOTION OF INSULIN SECRETION BY GLUCAGON. Lancet. 1965 Aug 28;2(7409):415–416. doi: 10.1016/s0140-6736(65)90761-0. [DOI] [PubMed] [Google Scholar]
  24. SOKAL J. E., SARCIONE E. J. Effect of epinephrine on glycogen stores. Am J Physiol. 1959 Jun;196(6):1253–1257. doi: 10.1152/ajplegacy.1959.196.6.1253. [DOI] [PubMed] [Google Scholar]
  25. Sherline P., Lynch A., Glinsmann W. H. Cyclic AMP and adrenergic receptor control of rat liver glycogen metabolism. Endocrinology. 1972 Sep;91(3):680–690. doi: 10.1210/endo-91-3-680. [DOI] [PubMed] [Google Scholar]
  26. Unger R. H. Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes. 1971 Dec;20(12):834–838. doi: 10.2337/diab.20.12.834. [DOI] [PubMed] [Google Scholar]
  27. Unger R. H. The organ of Langerhans in new perspective. Am J Med Sci. 1970 Aug;260(2):79–81. doi: 10.1097/00000441-197008000-00001. [DOI] [PubMed] [Google Scholar]
  28. Wise J. K., Hendler R., Felig P. Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects. N Engl J Med. 1973 Mar 8;288(10):487–490. doi: 10.1056/NEJM197303082881003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES